Dr. Nandini Tandon

In 2015, she received the Pravasi Bharatiya Samman Award, honor conferred by President of India, for her contribution to early detection in breast cancer. She received the Uttar Pradesh Ratna award in 2016 and the Women of Excellence Award, in USA in 2017.

Dr. Tandon is a strong champion of health equity, prioritizing early detection, economic equity, criticality of women’s engagement in STEM and inclusion women-led developments. Nandini has spoken globally on entrepreneurship, venture capital, innovation, health, economic and gender equity.

As a venture capitalist, Nandini has had a very successful track record. She made twelve investments with eleven exits, nine portfolio companies being acquired by market leaders such as Pfizer, Gilead, Amgen, General Electric and 2 companies following the IPO route. Dr. Tandon was Managing Director, Lumira/MDS Capital in Palo Alto with 1.2 billion USD under management and before was Partner, RBC Capital Partners, in San Francisco, responsible for establishing both the VC offices in Bay Area.

She was the Vice Chair of El Camino Hospital, in Silicon Valley. It is the world’s most technologically advanced hospital. As board member on hospitals in USA, UK, GCC, and India, she has taken strong leadership position during and post Covid to ensure public health is addressed equitably.

Prior to being a venture capitalist, she was Chief Business Officer for Zyomyx Inc., Vice President of Business Development for Hyseq Inc., with corporate development at Chiron Corp., was engaged with launch of Zofran and Imitrex with GlaxoWellcome and did research at Semiconductor Think tank, Microelectronic Center of North Carolina, RTP, NC, receiving a global patent.

Nandini was speaker at Davos, as a woman leader in STEM, and White house, was a delegate and speaker for Global Entrepreneurship Summit, GES, in Hague and Hyderabad under President Trump and at GES in Turkey and Dubai, under President Obama’s leadership.

Nandini Chaired,”20/20 Vision: Investing in USA & Emerging Markets” at Stanford University, was Board Member, University of California, Berkeley, Center for Emerging and Neglected Diseases; Board Member, C21 BioVentures; and has been on 14 for profit boards and 15 not for profit board.

A White House Intern, Nandini received Ph.D. in biochemistry, Phi Lambda Upsilon from Duke University, North Carolina and B.A. cum laude, Phi Beta Kappa from Hollins University, Virginia. She lives with her husband and son in Bay Area, CA.